EDSA
EDSA
NASDAQ · Biotechnology

Edesa Biotech Inc

Biotech Stocks Healthcare Stocks
$13.05
-1.56 (-10.68%)
As of May 16, 2:31 AM ET ·
Analyst Consensus
Strong Buy
8
Analysts
Moderate
Coverage
Buy 7 88%
Hold 1 13%
Sell 0 0%
Price Target
Analyst Price Target +131.0% upside
Low Target $22.58
Average Target $30.14
High Target $41.69
Current Price $13.05
Current
$13.05
Target
$30.14
$22.58 $30.14 avg $41.69
Scenario Analysis
Bear Case
$22.58
73.0%
Low target
Base Case
$30.14
+131.0%
Avg target
Bull Case
$41.69
+219.5%
High target
Risk/Reward
3.0x
Highly favorable
Price in Context
52-Week High
$20.32
-35.8% from high
52-Week Low
$0.72
+1,712.5% from low
Target vs 52W High
$30.14
+48.3% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 40 75% $257.58 +22.4%
AMGN
Amgen Inc
 Hold 44 48% $190.87 -41.5%
GILD
Gilead Sciences Inc
 Strong Buy 39 79% $362.68 +179.9%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 79% $438.34 +0.3%
REGN
Regeneron Pharmaceuticals
 Strong Buy 38 79% $76.80 -89.0%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 36 75% $102.31 -64.3%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -21.7%
BIIB
Biogen Inc
 Buy 43 56% $91.45 -52.6%